←WAYWaystar HoldingOur view: NeutralFull analysisעברית
Updated 16 Nov 2026
The company · 1 · Who is this company?

Waystar gets hospitals paid

About 30,000

healthcare providers use it

7.5 billion

transactions a year

Insurers

the bills it chases

A provider must check insurance, get permission, send a claim the insurer accepts, fight refusals and bill the patient. Waystar's software does those steps.

The company · 2 · What exactly does it sell?

Subscriptions are over half of sales

Each $1 of sales, first half of 2026
54%26%19%2%
Provider subscriptionsFees on patient paymentsFees per claimSet-up and other

The rest is fees per claim or payment, which grow with how many patients providers see.

The company · 3 · How does it make money?

A fee per subscription and per claim

About 97%of revenue kept each year
98%of 2025 revenue from existing clients
43%adjusted profit per $1

Almost no client leaves, so most of each year's revenue is already in place before it starts.

Is it a good business? · 4 · What gives it an edge?

Wired into every link of the billing

About 97%

of revenue kept each year

85%

of contested renewals won

Moving means retesting every link to the record system, bank and insurers while cash keeps coming in.

Is it a good business? · 5 · What is the catch?

Epic does it inside the hospital

EpicAI that drafts appeals
Optumthrough Change Healthcare

Listed rivals: UNH · EXPN.L · ORCL

Epic already sits inside the hospital and needs no new wiring, which undercuts exactly what keeps Waystar's clients. Large systems can also fight refusals with their own staff.

Is it a good business? · 6 · What does its record show?

Profit per $1 widened as sales grew

Sales, $B
0.7
0.8
0.9
1.1
1.3
Dec 2022Dec 2023Dec 2024Dec 2025last 12 mo
Sales$0.7B → $1.3Bsales, 2022 to the past year
Profit13% → 23%operating profit per $1
Share pay1% → 4%share pay as a part of sales

Share pay and research rose as a share of sales since 2022.

Is it a good business? · 7 · How much room is there to grow?

Providers spend billions fighting refusals

About $19.7Ba year spent fighting denied claims
About 15%of claims to private insurers denied at first
About 5%the market's yearly growth

Waystar's 2025 revenue was about 5.6% of that sum: large, but growing slowly.

Is it a good business? · 8 · Who is in charge?

Buyout firms decide whether to sell

Since 2017Matt Hawkins chief executive
13.0%held by EQT, the largest of four buyout owners
July 2026a new finance chief

Bonuses ride on revenue and adjusted profit; insider sales were almost all under preset plans.

The story right now · 9 · Will AI take Waystar's work?

AI is Waystar's product too

About 40%of new sales were AI tools
EpicAI that drafts appeals
-29%Waystar's shares in a year

AI can read a refusal and draft the appeal. The market fears it lets others do Waystar's job; Waystar sells AI tools of its own.

The story right now · 10 · What makes billing software sticky?

Switching risks a hospital's cash

  1. Software links to everythingRecords, banks, insurers.
  2. Cash flows through itEvery day.
  3. Switching means retestingEvery link, while billing.
  4. So clients stayAbout 97% of revenue kept.

Existing clients' added spending slipped to 107.6% from 108.3%, mostly as a one-off lift from an outage at a rival faded.

The story right now · 11 · What changed lately?

Revenue rose 21% and profit forecasts went up

$325.6Mrevenue, up 21%
43%adjusted profit per $1
+8%fees on claims
About 6%implied fourth-quarter growth

Mixed quarter

The shares fell 29% in a year, and rose 7.1% on a report that the owners are exploring a sale.

The story right now · 12 · What is everyone arguing about?

Does AI shrink this work, or sell more of it?

Many investors think

AI and record vendors will take this work

We think

The work is sticky and growth near today's pace is likely

Against us: Epic already sits inside the hospital. If retention keeps falling, the market is right.

The price and our view · 13 · What is a share worth?

The price sits about a fifth below our value

$35.98what we think a share is worth
$35.98our value
Attractive
below $26.98
Neutral
Unattractive
above $43.18
$16.90gloomy: growth halves and less kept per $1
$35.98our estimate: experts' path, then slowing
$48.55sunny: growth runs faster

Value per share in three futures. None is a prediction of the share price.

We estimate what a share is worth from the cash the business should earn over many years. Our rule: buy only when the price is at least a fifth below our estimate, as a cushion for being wrong.

The price and our view · 14 · How could we be wrong?

Epic, floating-rate debt and a sale

Epic does it insideBiggest

No second vendor needed.

A sale on owners' termsShowing now

Bankers reportedly hired.

Another breachWatch

Source code taken in June.

Where retention settlesUnknown

After outage clients count.

About $1.28B of debt pays interest that rises with rates, and patient visits grow only 1% to 2% a year.

The price and our view · 15 · How will we know?

February brings the 2027 forecast

Growth, leaving out the Iodine purchase, near 8% to 10%Good sign
Clients' added spending steady near 108%Good sign
Growth under 7%, or that figure under 107%Bad sign
FEB 202716

Fourth-quarter 2026 results and 2027 forecast, 16 February. Companies report every three months; each report is a test of the story.

Our view also changes on price alone: we turn positive if the shares fall a quarter below our estimate, and negative a fifth above it.

The price and our view · 16 · So, what do we think?

The pipes hospitals bill through, fairly priced

$35.98our value
Attractive
below $26.98
Neutral
Unattractive
above $43.18

NeutralMedium conviction

Waystar's software checks, sends and chases payment for about 30,000 healthcare providers, and almost none leave. The price pays for growth near today's pace, with Epic the main threat. Neutral.

↑ ↓ to move · C for contents